Tesamorelin & Ipamorelin Blend – Technical Specifications
| Characteristic | Description |
|---|---|
| Product Composition | Supplied as a Tesamorelin/Ipamorelin dual-peptide blend in lyophilized powder form with 99% purity, packaged in a 3mL vial. |
| Available Strengths | Available in 10mg/3mg and 5mg/5mg formulations (Tesamorelin/Ipamorelin). |
| Peptide Classification | Combination peptide blend consisting of Tesamorelin, a synthetic 44–amino acid GHRH analog, and Ipamorelin, a synthetic pentapeptide GHS-R1a receptor agonist. |
| Purity Standard | Verified at 99% purity through HPLC-MS analysis and independent third-party laboratory testing. |
| Chemical Formulae | Tesamorelin: C221H366N72O67S; Ipamorelin: C38H49N9O5. |
| Molecular Mass | Tesamorelin: 5135.91 g/mol; Ipamorelin: 711.86 g/mol. |
| Amino Acid Sequences | Tesamorelin: (trans-3-hexenoic acid)-YADAIFTNSY RKVLGQLSAR KLLQDIMSR QQGESNQERG ARARL-NH₂; Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH₂. |
| CAS Registry Numbers | Tesamorelin: 218949-48-5; Ipamorelin: 170851-70-4. |
| PubChem Identifiers | Tesamorelin: 16137828; Ipamorelin: 9831659. |
| Physical Appearance | White to slightly off-white freeze-dried powder. |
| Recommended Storage | Store refrigerated at or below 6°C in a tightly sealed container, protected from heat, moisture, and direct light exposure. |
| Solubility Characteristics | Readily soluble in water. |




Reviews
There are no reviews yet.